In vitro activity of BMY-28100, a new oral cephalosporin.

The activity of BMY-28100, a new orally administered cephalosporin, was compared with those of cephalexin and cefaclor. BMY-28100 was the most active drug against Staphylococcus aureus (MIC for 90% of strains tested [MIC90], 1.0 microgram/ml), streptococci (MIC90S, less than or equal to 0.125 microg...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Eliopoulos, G M, Reiszner, E, Wennersten, C, Moellering, R C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174801/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3496846/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.653
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!